These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 24202667)

  • 21. Randomized phase II and pharmacogenetic study of pemetrexed compared with pemetrexed plus carboplatin in pretreated patients with advanced non-small-cell lung cancer.
    Smit EF; Burgers SA; Biesma B; Smit HJ; Eppinga P; Dingemans AM; Joerger M; Schellens JH; Vincent A; van Zandwijk N; Groen HJ
    J Clin Oncol; 2009 Apr; 27(12):2038-45. PubMed ID: 19307503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concomitant chemoradiotherapy using pemetrexed and carboplatin for unresectable stage III non-small cell lung cancer (NSCLC): preliminary results of a phase II study.
    Xu Y; Ma S; Ji Y; Sun X; Jiang H; Chen J; Du X; Zheng Y; Qiu G
    Lung Cancer; 2011 Jun; 72(3):327-32. PubMed ID: 21056507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A case series of NSCLC patients with different molecular characteristics and choroidal metastases: improvement in vision with treatment including pemetrexed and bevacizumab.
    Riess JW; Nagpal S; Das M; Neal JW; Kim JW; Wakelee HA
    J Thorac Oncol; 2013 Feb; 8(2):e17-8. PubMed ID: 23328555
    [No Abstract]   [Full Text] [Related]  

  • 24. A phase II randomized study of cisplatin-pemetrexed plus either enzastaurin or placebo in chemonaive patients with advanced non-small cell lung cancer.
    Vansteenkiste J; Ramlau R; von Pawel J; San Antonio B; Eschbach C; Szczesna A; Kennedy L; Visseren-Grul C; Chouaki N; Reck M
    Oncology; 2012; 82(1):25-9. PubMed ID: 22269428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pemetrexed and cisplatin with concurrent radiotherapy for locally advanced non-small cell and limited disease small cell lung cancer: results from 2 phase I studies.
    Surmont V; Smit EF; de Jonge M; Aerts JG; Nackaerts K; Vernhout R; Gras J; Van Wijk A; Phernambucq EC; van Meerbeeck JP; Senan S; Kraaij CJ; Chouaki N; Praag J; van Klaveren RJ
    Lung Cancer; 2010 Sep; 69(3):302-6. PubMed ID: 20096951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PROCLAIM: A phase III study of pemetrexed, cisplatin, and radiation therapy followed by consolidation pemetrexed versus etoposide, cisplatin, and radiation therapy followed by consolidation cytotoxic chemotherapy of choice in locally advanced stage III non-small-cell lung cancer of other than predominantly squamous cell histology.
    Vokes EE; Senan S; Treat JA; Iscoe NA
    Clin Lung Cancer; 2009 May; 10(3):193-8. PubMed ID: 19443340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic evaluation of platinum derived from cisplatin administered alone and with pemetrexed in head and neck cancer patients.
    Specenier PM; Ciuleanu T; Latz JE; Musib LC; Darstein CL; Vermorken JB
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):233-41. PubMed ID: 19011858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pemetrexed in first-line treatment of non-small cell lung cancer.
    Esteban E; Casillas M; Cassinello A
    Cancer Treat Rev; 2009 Jun; 35(4):364-73. PubMed ID: 19269106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and clinical characteristics of symptomatic choroidal metastasis from lung cancer.
    Kreusel KM; Bechrakis NE; Wiegel T; Krause L; Foerster MH
    Acta Ophthalmol; 2008 Aug; 86(5):515-9. PubMed ID: 18081901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non squamous, non-small cell lung cancer (NSCLC)].
    Tredaniel J; Mornex F; Barillot I; Diaz O; Hennequin C; Le Pechoux C; Lavole A; Giraud P; Souquet PJ; Teixeira L; Vaylet F; Zalcman G; Baudrin L; Morin F; Milleron B
    Rev Mal Respir; 2011 Jan; 28(1):51-7. PubMed ID: 21277474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer.
    Greenhalgh J; McLeod C; Bagust A; Boland A; Fleeman N; Dundar Y; Oyee J; Dickson R; Davis H; Green J; McKenna E; Pearson M
    Health Technol Assess; 2010 Oct; 14(Suppl. 2):33-9. PubMed ID: 21047489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study of pemetrexed in combination with cisplatin and cetuximab in recurrent or metastatic squamous cell carcinoma of the head and neck.
    Vermorken JB; Licitra L; Stöhlmacher-Williams J; Dietz A; Lopez-Picazo JM; Hamid O; Hossain AM; Chang SC; Gauler TC
    Eur J Cancer; 2013 Sep; 49(13):2877-83. PubMed ID: 23726971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II study of pemetrexed as first-line treatment in elderly (≥75) non-squamous non-small-cell lung cancer: Kyoto Thoracic Oncology Research Group Trial 0901.
    Kim YH; Hirabayashi M; Kosaka S; Nikaidoh J; Yamamoto Y; Shimada M; Toyazaki T; Nagai H; Sakamori Y; Mishima M
    Cancer Chemother Pharmacol; 2013 Jun; 71(6):1445-51. PubMed ID: 23532206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activity of Pemetrexed on brain metastases from Non-Small Cell Lung Cancer.
    Bearz A; Garassino I; Tiseo M; Caffo O; Soto-Parra H; Boccalon M; Talamini R; Santoro A; Bartolotti M; Murgia V; Berretta M; Tirelli U
    Lung Cancer; 2010 May; 68(2):264-8. PubMed ID: 19632738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An indirect comparison of the efficacy of bevacizumab plus carboplatin and paclitaxel versus pemetrexed with cisplatin in patients with advanced or recurrent non-squamous adenocarcinoma non-small cell lung cancer.
    Nuijten MJ; Aultman R; Carpeño Jde C; Vergnenègre A; Chouaid C; Walzer S; Siebert U
    Curr Med Res Opin; 2011 Nov; 27(11):2193-201. PubMed ID: 21970659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of late recurrent breast cancer that responded to radiation therapy and cisplatin plus pemetrexed therapy].
    Akimoto E; Ohara M; Noma M; Kamitsuna M; Nishizaka T; Itamoto T
    Gan To Kagaku Ryoho; 2013 Mar; 40(3):371-4. PubMed ID: 23507601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carcinoma lung presenting with choroidal metastasis as initial presentation: a rarity.
    Bhattacharyya T; Kapoor R; Bahl A; Yadav BS; Singh U; Joshi K; Rane S; Sharma SC
    J Cancer Res Ther; 2013; 9(3):504-6. PubMed ID: 24125993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Choroidal metastases of lung neoplasm treated with external radiotherapy and polychemotherapy: a study of four clinical cases].
    Barry AS; Bacin F; Kodjikian L; Benbouzid F; Balmitgere T; Grange JD
    J Fr Ophtalmol; 2012 Feb; 35(2):122.e1-8. PubMed ID: 22189456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Choroid metastases revealing pulmonary adenocarcioma resolved with chemotherapy].
    Battikh MH; Ben Yahia S; Ben Sayah MM; Maatallah A; Joobeur S; Rouatbi N; Khairallah M; El Kamel A
    Rev Pneumol Clin; 2004 Dec; 60(6 Pt 1):353-6. PubMed ID: 15699909
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Choroidal mass as the presenting sign of small cell lung carcinoma.
    Fernandes BF; Fernandes LH; Burnier MN
    Can J Ophthalmol; 2006 Oct; 41(5):605-8. PubMed ID: 17016534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.